(S)-(-)-[11C]nicotine binding assessed by PET: a dual tracer model evaluated in the rhesus monkey brain
- PMID: 9772029
- DOI: 10.1097/00002093-199809000-00018
(S)-(-)-[11C]nicotine binding assessed by PET: a dual tracer model evaluated in the rhesus monkey brain
Abstract
A dual tracer model, consisting of the administration of 15O-water and (S)-(-)-[11C]nicotine in close succession, is suggested to assess nicotine binding in the brain. Regional cerebral blood flow (rCBF) determined by 15O-water was used to flow compensate two nicotine model parameters, k1 and k2, obtained in a two-compartment kinetic model. In the present study, this dual tracer approach was evaluated in the rhesus monkey by altering the rCBF or by administering (S)-(-)-[11C]nicotine at either high or low specific radioactivity. The model parameter, k2' = k2/rCBF, was found to be independent of rCBF in different regions of interest in the monkey brain. The parameter, k2', increased significantly when (S)-(-)-[11C]nicotine was given at low specific radioactivity, indicating lower nicotine binding in the brain. Thus, this observation implies an influence on specific receptor binding on the corrected efflux rate constant. This dual tracer model may be useful in evaluating nicotine binding changes in the human brain and the effect of drug treatment in neurodegenerative disorders such as Alzheimer disease.
Similar articles
-
Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains--in vivo assessment using positron emission tomography.Alzheimer Dis Assoc Disord. 1995 Spring;9(1):21-7. doi: 10.1097/00002093-199505000-00006. Alzheimer Dis Assoc Disord. 1995. PMID: 7605618
-
Uptake and regional distribution of (+)-(R)- and (-)-(S)-N-[methyl-11C]-nicotine in the brains of rhesus monkey. An attempt to study nicotinic receptors in vivo.J Neural Transm Park Dis Dement Sect. 1989;1(3):195-205. doi: 10.1007/BF02248669. J Neural Transm Park Dis Dement Sect. 1989. PMID: 2789067
-
PET studies of the uptake of (S)- and (R)-[11C]nicotine in the human brain: difficulties in visualizing specific receptor binding in vivo.Psychopharmacology (Berl). 1994 Jun;115(1-2):31-6. doi: 10.1007/BF02244748. Psychopharmacology (Berl). 1994. PMID: 7862909 Clinical Trial.
-
Human brain mapping under increasing cognitive complexity using regional cerebral blood flow measurements and positron emission tomography.Dan Med Bull. 2007 Nov;54(4):289-305. Dan Med Bull. 2007. PMID: 18208679 Review.
-
Radioactive oxygen-15 in the study of cerebral blood flow, blood volume, and oxygen metabolism.Semin Nucl Med. 1985 Oct;15(4):377-94. doi: 10.1016/s0001-2998(85)80015-5. Semin Nucl Med. 1985. PMID: 3904006 Review.
Cited by
-
Evaluation of an Image-Derived Input Function for Kinetic Modeling of Nicotinic Acetylcholine Receptor-Binding PET Ligands in Mice.Int J Mol Sci. 2023 Oct 24;24(21):15510. doi: 10.3390/ijms242115510. Int J Mol Sci. 2023. PMID: 37958495 Free PMC article.
-
Use of carbon-11 nicotine in PET studies.Eur J Nucl Med. 1997 Jul;24(7):825-6. doi: 10.1007/BF00879673. Eur J Nucl Med. 1997. PMID: 9289404 No abstract available.
-
PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.Psychopharmacology (Berl). 2006 Nov;188(4):509-20. doi: 10.1007/s00213-006-0447-7. Epub 2006 Jul 11. Psychopharmacology (Berl). 2006. PMID: 16832659 Clinical Trial.
-
Clinical Perspective and Recent Development of PET Radioligands for Imaging Cerebral Nicotinic Acetylcholine Receptors.PET Clin. 2009 Jan 1;4(1):89-100. doi: 10.1016/j.cpet.2009.04.014. PET Clin. 2009. PMID: 20046884 Free PMC article. No abstract available.
-
Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.Psychopharmacology (Berl). 2007 May;191(4):1005-14. doi: 10.1007/s00213-007-0725-z. Epub 2007 Feb 20. Psychopharmacology (Berl). 2007. PMID: 17310387 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources